Buparlisib T1827
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Buparlisib is an orally bioavailable specific oral inhibitor of the pan-class I PI3K (IC50s: 52/166/116/nM for p110_, p110_, and p110_).
CAS nr:
944396-07-0
Purity:
98%
Molecular Weight:
410,39
SMILES:
Nc1cc(c(cn1)-c1cc(nc(n1)N1CCOCC1)N1CCOCC1)C(F)(F)F
Formula:
C18H21F3N6O2
Pathway:
PI3K/Akt/mTOR signaling,Apoptosis
Target:
PI3K,Apoptosis
